Boley P, Dennis P, Faraone J, Xu J, Liu M, Niu X
Viruses. 2023; 15(7).
PMID: 37515289
PMC: 10385782.
DOI: 10.3390/v15071603.
Bloch E, Kyeyune D, White J, Ddungu H, Ashokkumar S, Habtehyimer F
Transfusion. 2023; 63(7):1354-1365.
PMID: 37255467
PMC: 10525030.
DOI: 10.1111/trf.17449.
Devaux C, Fantini J
Pathogens. 2023; 12(5).
PMID: 37242383
PMC: 10220573.
DOI: 10.3390/pathogens12050713.
Norton N, Holder K, Ings D, Harnum D, Russell R, Grant M
Viruses. 2023; 15(4).
PMID: 37112977
PMC: 10144856.
DOI: 10.3390/v15040996.
Harrison C, Doster J, Landwehr E, Kumar N, White E, Beachboard D
Microorganisms. 2023; 11(2).
PMID: 36838410
PMC: 9961755.
DOI: 10.3390/microorganisms11020445.
Recent advances in immunoassay technologies for the detection of human coronavirus infections.
Wang D, Chen Y, Xiang S, Hu H, Zhan Y, Yu Y
Front Cell Infect Microbiol. 2023; 12:1040248.
PMID: 36683684
PMC: 9845787.
DOI: 10.3389/fcimb.2022.1040248.
Comparable diagnostic accuracy of SARS-CoV-2 Spike RBD and N-specific IgG tests to determine pre-vaccination nation-wide baseline seroprevalence in Mexico.
Martinez-Barnetche J, Carnalla M, Gaspar-Castillo C, Basto-Abreu A, Lizardi R, Antonio R
Sci Rep. 2022; 12(1):18014.
PMID: 36289305
PMC: 9606250.
DOI: 10.1038/s41598-022-22146-8.
Role of the humoral immune response during COVID-19: guilty or not guilty?.
Yaugel-Novoa M, Bourlet T, Paul S
Mucosal Immunol. 2022; 15(6):1170-1180.
PMID: 36195658
PMC: 9530436.
DOI: 10.1038/s41385-022-00569-w.
Laboratory and Point-of-Care Testing for COVID-19: A Review of Recent Developments.
Kalia R, Kaila R, Kahar P, Khanna D
Cureus. 2022; 14(8):e28530.
PMID: 36185888
PMC: 9517582.
DOI: 10.7759/cureus.28530.
SARS-CoV-2-specicific humoral immunity in convalescent patients with mild COVID-19 is supported by CD4 T-cell help and negatively correlated with Alphacoronavirus-specific antibody titer.
Odendahl M, Endler I, Haubold B, Rodionov R, Bornstein S, Tonn T
Immunol Lett. 2022; 251-252:38-46.
PMID: 36174771
PMC: 9512529.
DOI: 10.1016/j.imlet.2022.09.007.
Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccination.
Hu C, Wang Z, Ren L, Hao Y, Zhu M, Jiang H
Front Cell Infect Microbiol. 2022; 12:978440.
PMID: 36118022
PMC: 9478943.
DOI: 10.3389/fcimb.2022.978440.
Estimating the effect of non-pharmaceutical interventions on US SARS-CoV-2 infections in the first year of the pandemic.
Duncan N, LHer G, Osborne A, Sawyer S, Deinert M
R Soc Open Sci. 2022; 9(6):210875.
PMID: 35774134
PMC: 9240671.
DOI: 10.1098/rsos.210875.
The humoral response and antibodies against SARS-CoV-2 infection.
Qi H, Liu B, Wang X, Zhang L
Nat Immunol. 2022; 23(7):1008-1020.
PMID: 35761083
DOI: 10.1038/s41590-022-01248-5.
The Role of Antibodies in the Treatment of SARS-CoV-2 Virus Infection, and Evaluating Their Contribution to Antibody-Dependent Enhancement of Infection.
Farouq M, Acevedo R, Ferro V, Mulheran P, Al Qaraghuli M
Int J Mol Sci. 2022; 23(11).
PMID: 35682757
PMC: 9181534.
DOI: 10.3390/ijms23116078.
Cross-Recognition of SARS-CoV-2 B-Cell Epitopes with Other Betacoronavirus Nucleoproteins.
Tajuelo A, Lopez-Siles M, Mas V, Perez-Romero P, Aguado J, Briz V
Int J Mol Sci. 2022; 23(6).
PMID: 35328398
PMC: 8955325.
DOI: 10.3390/ijms23062977.
Community seroprevalence and risk factors for SARS-CoV-2 infection in different subpopulations in Vellore, India, and their implications for future prevention.
Dayanand D, Irudhayanathan I, Kundu D, Manesh A, Abraham V, Abhilash K
Int J Infect Dis. 2021; 116:138-146.
PMID: 34971822
PMC: 8712712.
DOI: 10.1016/j.ijid.2021.12.356.
Effective presence of antibodies against common human coronaviruses in immunoglobulin medicinal products.
Diez J, Romero C, Gajardo R
Int J Infect Dis. 2021; 116:68-73.
PMID: 34929360
PMC: 8679496.
DOI: 10.1016/j.ijid.2021.12.329.
How immunity from and interaction with seasonal coronaviruses can shape SARS-CoV-2 epidemiology.
Waterlow N, van Leeuwen E, Davies N, Flasche S, Eggo R
Proc Natl Acad Sci U S A. 2021; 118(49).
PMID: 34873059
PMC: 8670441.
DOI: 10.1073/pnas.2108395118.
A Comprehensive Review about the Molecular Structure of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Insights into Natural Products against COVID-19.
Saied E, El-Maradny Y, Osman A, Darwish A, Abo Nahas H, Niedbala G
Pharmaceutics. 2021; 13(11).
PMID: 34834174
PMC: 8624722.
DOI: 10.3390/pharmaceutics13111759.
Heterologous humoral immunity to human and zoonotic coronaviruses: Aiming for the achilles heel.
Ng K, Faulkner N, Wrobel A, Gamblin S, Kassiotis G
Semin Immunol. 2021; 55:101507.
PMID: 34716096
PMC: 8542444.
DOI: 10.1016/j.smim.2021.101507.